FDA Brief

Company record

Sato Pharmaceutical Co., Ltd.

1 FDA warning letter since 2023 and 2 recalls in the last 12 months.

Get an email the day FDA posts anything new about Sato Pharmaceutical Co., Ltd..

Warning letters

  1. Sato Pharmaceutical Co., Ltd.

    FDA says Sato Pharmaceutical's sterile OTC drug line had contamination and stability failures.

    High risk

Recalls

ReportedClassFirmProduct and reason
Jun 10 Class III Sato Pharmaceutical Inc.
Food
Yunker(branded) Energy & Health Herbal Supplement with Vitamins; Manufactured by Sato Pharmaceuticals Co. Ltd.; 30ml container. Packed in single serving, 3 units/pack, and 10 units per pack. Single UPC: 49873-916-11 3pa…
Product does not meet label claim for Vitamin E.
Feb 4 Class II Sato Pharmaceutical Co., Ltd
Drug
INON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle, Manufactured by: Sato Pharmaceutical Co., Ltd., NDC 49873-402-01
Failed Disintegration Specifications: above the time expected.